3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
09 06 2023
Historique:
medline: 9 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

Routine clinical assays, such as conventional immunohistochemistry, often fail to resolve the regional heterogeneity of complex inflammatory skin conditions. We introduce MANTIS (Multiplex Annotated Tissue Imaging System), a flexible analytic pipeline compatible with routine practice, specifically designed for spatially resolved immune phenotyping of the skin in experimental or clinical samples. On the basis of phenotype attribution matrices coupled to α-shape algorithms, MANTIS projects a representative digital immune landscape while enabling automated detection of major inflammatory clusters and concomitant single-cell data quantification of biomarkers. We observed that severe pathological lesions from systemic lupus erythematosus, Kawasaki syndrome, or COVID-19-associated skin manifestations share common quantitative immune features while displaying a nonrandom distribution of cells with the formation of disease-specific dermal immune structures. Given its accuracy and flexibility, MANTIS is designed to solve the spatial organization of complex immune environments to better apprehend the pathophysiology of skin manifestations.

Identifiants

pubmed: 37285432
doi: 10.1126/sciadv.adf9491
pmc: PMC10246893
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadf9491

Références

ACS Comb Sci. 2018 Nov 12;20(11):653-659
pubmed: 30339749
Elife. 2018 Jul 11;7:
pubmed: 29993362
J Immunol. 2000 Nov 1;165(9):5338-44
pubmed: 11046069
Nat Biomed Eng. 2017 Sep;1(9):697-713
pubmed: 31015673
Nat Biotechnol. 2019 Sep;37(9):1080-1090
pubmed: 31427819
Genome Med. 2022 Jun 27;14(1):68
pubmed: 35761361
Nat Rev Immunol. 2009 Oct;9(10):679-91
pubmed: 19763149
Acta Cardiol. 2010 Oct;65(5):571-3
pubmed: 21125980
Nat Methods. 2021 Sep;18(9):997-1012
pubmed: 34341583
Autoimmun Rev. 2004 Mar;3(3):215-20
pubmed: 15110234
J Immunol. 2008 Dec 15;181(12):8761-6
pubmed: 19050297
Br J Dermatol. 2020 Jul;183(1):71-77
pubmed: 32348545
Lancet Infect Dis. 2021 Mar;21(3):313-314
pubmed: 33460566
Nat Protoc. 2019 Jun;14(6):1708-1733
pubmed: 31028373
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e440-e441
pubmed: 32421876
Nat Protoc. 2021 Aug;16(8):3802-3835
pubmed: 34215862
Nat Rev Mol Cell Biol. 2019 May;20(5):285-302
pubmed: 30659282
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293
pubmed: 32330334
Nat Rev Immunol. 2019 Jan;19(1):19-30
pubmed: 30429578
Science. 2021 Jun 11;372(6547):
pubmed: 34112666
Neth J Med. 1998 Feb;52(2):79-81
pubmed: 9557531
J Am Acad Dermatol. 2020 May;82(5):e177
pubmed: 32213305
Nat Methods. 2014 Apr;11(4):417-22
pubmed: 24584193
Nat Rev Immunol. 2019 Aug;19(8):490-502
pubmed: 30992525
Nat Immunol. 2013 Oct;14(10):978-85
pubmed: 24048119
Cell. 2018 Aug 9;174(4):968-981.e15
pubmed: 30078711
Immunity. 2012 Aug 24;37(2):364-76
pubmed: 22863836
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Sci Adv. 2019 Oct 09;5(10):eaax5851
pubmed: 31633026
Curr Opin Rheumatol. 2021 Mar 1;33(2):163-172
pubmed: 33394752
Cancer Immunol Immunother. 2016 Apr;65(4):441-52
pubmed: 26850637
Nat Immunol. 2019 Nov;20(11):1435-1443
pubmed: 31591569
J Immunol. 2019 Mar 15;202(6):1659-1666
pubmed: 30833422
Eur Respir J. 1999 Apr;13(4):930-3
pubmed: 10362064
Exp Ther Med. 2019 Aug;18(2):888-894
pubmed: 31384319
Am J Dermatopathol. 2021 Apr 1;43(4):e47-e50
pubmed: 33156022
BMC Evol Biol. 2018 Dec 5;18(1):184
pubmed: 30518326
Cell Rep. 2020 Dec 15;33(11):108501
pubmed: 33326780
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e252-e254
pubmed: 32294262
J Invest Dermatol. 2013 Apr;133(4):973-9
pubmed: 23223131
J Am Acad Dermatol. 2020 Sep;83(3):870-875
pubmed: 32502585
Nat Commun. 2021 Nov 18;12(1):6726
pubmed: 34795254
BMC Bioinformatics. 2022 Jan 18;23(1):46
pubmed: 35042474
Front Immunol. 2022 Feb 10;13:816005
pubmed: 35222392
Br J Dermatol. 2020 Oct;183(4):729-737
pubmed: 32562567
J Clin Med. 2021 May 19;10(10):
pubmed: 34069751
Pediatr Neurol. 2021 Feb;115:1-6
pubmed: 33307271
Int J Dermatol. 2020 Jun;59(6):739-743
pubmed: 32329897

Auteurs

Manon Scholaert (M)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.
Genoskin SAS, Toulouse, France.

Raissa Houmadi (R)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.

Jeremy Martin (J)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.

Nadine Serhan (N)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.

Marie Tauber (M)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.
Department of Allergology and Clinical Immunology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
Centre International de Recherche en Infectiologie (CIRI; Team Immunology of Skin Allergy and Vaccination), Inserm U1111, Université Claude Bernard Lyon 1, and CNRS, UMR5308, Lyon, France.
ENS de Lyon, F-69007 Lyon, France.

Emilie Braun (E)

Genoskin SAS, Toulouse, France.

Lilian Basso (L)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.

Eric Merle (E)

Genoskin Inc, Salem, MA, USA.

Pascal Descargues (P)

Genoskin Inc, Salem, MA, USA.

Manuelle Viguier (M)

Dermatology Department, Hôpital Robert Debré, EA7509 IRMAIC, Université Reims Champagne Ardenne, Reims, France.

Cécile Lesort (C)

Centre International de Recherche en Infectiologie (CIRI; Team Immunology of Skin Allergy and Vaccination), Inserm U1111, Université Claude Bernard Lyon 1, and CNRS, UMR5308, Lyon, France.
Department of Dermatology Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

Benoît Chaput (B)

Department of Plastic, Reconstructive and Aesthetic Surgery, Rangueil Hospital, CHU Toulouse, Toulouse, France.

Jean Kanitakis (J)

Centre International de Recherche en Infectiologie (CIRI; Team Immunology of Skin Allergy and Vaccination), Inserm U1111, Université Claude Bernard Lyon 1, and CNRS, UMR5308, Lyon, France.
Department of Dermatology Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

Denis Jullien (D)

Centre International de Recherche en Infectiologie (CIRI; Team Immunology of Skin Allergy and Vaccination), Inserm U1111, Université Claude Bernard Lyon 1, and CNRS, UMR5308, Lyon, France.
Department of Dermatology Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

Cristina Bulai Livideanu (CB)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.
Department of Dermatology, Paul Sabatier University, Toulouse University Hospital, Toulouse, France.

Laurence Lamant (L)

Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, avenue Joliot-Curie, 31049 Toulouse, France.

Emeline Pagès (E)

Genoskin SAS, Toulouse, France.

Nicolas Gaudenzio (N)

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, and University Toulouse III, Toulouse, France.
Genoskin SAS, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH